About MICHR

The Michigan Institute for Clinical & Health Research (MICHR) is leading the way in building the field of translational science with the intent of extending life and reducing the impact of illness and disability.

NIH: The National Center for Advancing Translational Sciences. Collaborate. Innovate. Accelerate.

MICHR is developing and demonstrating scientific and operational innovations in the translational process and disseminating these solutions nationally.

a group of people around tables working and talking

History

Founded in 2006, MICHR received a Clinical and Translational Science Award in 2007 from the National Institutes of Health (NIH). Renewed in 2012, 2017, and 2023, MICHR is part of a national consortium of more than 60 academic research institutions funded by the CTSA program, accelerating discoveries toward better health.

Executive Leadership

Julie Lumeng

Executive Director & Principal Investigator

Erica Marsh

Associate Director & Co-Principal Investigator

Vicki Ellingrod

Associate Director

Beth LaPensee

Managing Director, Research Strategy

LaTonya Berryhill

Managing Director, Operations

Program Leads

LaTonya Berryhill, MBA
Sue Burhop, BS, MT, ASCP
Brenda Eakin, MS, ACSM-CEP
Vicki Ellingrod, PharmD
Polly Gipson Allen, PhD
David Hanauer, MD, MS
Diane Harper, MD, MPH, MS
Mike Holinstat, PhD
Rula Karapatsakis, MS
Amy Kilbourne, PhD, MPH

Beth LaPensee, PhD
Erica Marsh, MD
Jim Maszatics, BA
Susan Murphy, PhD, ScD, OTR
Tricia Piechowski, MPH, MSW, MA
Eli Samuels, PhD
Emily Somers, PhD, ScM
Cathie Spino, ScD
Dave Williams, PhD
Jeanne Wright, RAC